PubRank

L Moreland

Author PubWeight™ 17.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 1999 3.10
2 The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol 2011 2.54
3 Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000 1.82
4 Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis 2006 1.70
5 Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum 2001 1.68
6 The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 2001 1.42
7 Intraarticular corticosteroid injections: should we rest the joints? Arthritis Care Res 1989 1.41
8 Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999 1.16
9 Access to disease modifying treatments for rheumatoid arthritis patients. Ann Rheum Dis 1999 0.89
10 Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Rheumatology (Oxford) 2001 0.85
11 Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy. ASAIO J 1996 0.76
12 Comment on the article by Furst et al. Arthritis Rheum 1989 0.75
13 Improved methotrexate patient information. Arthritis Rheum 1995 0.75
14 The treatment of rheumatoid arthritis: a review of recent clinical trials. Curr Rheumatol Rep 1999 0.75